ロード中...
Systemic carboplatin for retinoblastoma: change in tumour size over time
Background/aim: Chemotherapy for intraocular retinoblastoma is used to shrink individual retinal tumours to a size amenable to focal treatments. Quantitative data regarding retinal tumour response following treatment with primary systemic carboplatin are reported. Methods: Changes in area and larges...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Copyright 2005 British Journal of Ophthalmology
2005
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1772963/ https://ncbi.nlm.nih.gov/pubmed/16299142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2005.072033 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|